Journal of Biological Chemistry · 1999 · 66 citations · 28 references
Life SciencesBiochemistryMolecular BiologyInnate ImmunityProtein EngineeringSignal TransductionBacterial ToxinsSmall Gtpase SignalingEnzymatic Toxin ActivityMicrobial ToxinsProtein ToxinsRho Family Gtpase SignalingRho Family GtpasesToxin EnzymologyToxin FunctionToxin Structure
The Escherichia coli cytotoxic necrotizing factor 1 (CNF1) and the Bordetelladermonecrotic toxin (DNT) activate Rho GTPases by deamidation of Gln63 of RhoA (Gln61 of Cdc42 and Rac). In addition, both toxins possess in vitro transglutaminase activity in the presence of primary amines. Here we characterized the region of Rho essential for substrate recognition by the toxins using Rho/Ras chimeras as protein substrates. The chimeric protein Ras55Rho was deamidated or transglutaminated by CNF1. Rat pheochromocytoma PC12 cells microinjected with Ras55Rho developed formation of neurite-like structures after treatment with the CNF1 holotoxin indicating activation of the Ha-Ras chimera and Ras-like effects in intact cells. The Ras59Rho78Ras chimera protein contained the minimal Rho sequence allowing deamidation or transglutamination by CNF1. A peptide covering mainly the switch II region and consisting of amino acid residues Asp59 through Asp78 of RhoA was substrate for CNF1. Changes of amino acid residues Arg68 or Leu72 of RhoA into the corresponding residues of Ras (R68ARhoA and L72QRhoA) inhibited deamidation and transglutamination of the mutants by CNF1. In contrast to CNF1, DNT did not modify Rho/Ras chimeras or the switch II peptide (Asp59 through Asp78). Glucosylation of RhoA at Thr37 blocked deamidation by DNT but not by CNF. The data indicate that CNF1 recognizes Rho GTPases exclusively in the switch II region, whereas the substrate recognition by DNT is characterized by additional structural requirements. The Escherichia coli cytotoxic necrotizing factor 1 (CNF1) and the Bordetelladermonecrotic toxin (DNT) activate Rho GTPases by deamidation of Gln63 of RhoA (Gln61 of Cdc42 and Rac). In addition, both toxins possess in vitro transglutaminase activity in the presence of primary amines. Here we characterized the region of Rho essential for substrate recognition by the toxins using Rho/Ras chimeras as protein substrates. The chimeric protein Ras55Rho was deamidated or transglutaminated by CNF1. Rat pheochromocytoma PC12 cells microinjected with Ras55Rho developed formation of neurite-like structures after treatment with the CNF1 holotoxin indicating activation of the Ha-Ras chimera and Ras-like effects in intact cells. The Ras59Rho78Ras chimera protein contained the minimal Rho sequence allowing deamidation or transglutamination by CNF1. A peptide covering mainly the switch II region and consisting of amino acid residues Asp59 through Asp78 of RhoA was substrate for CNF1. Changes of amino acid residues Arg68 or Leu72 of RhoA into the corresponding residues of Ras (R68ARhoA and L72QRhoA) inhibited deamidation and transglutamination of the mutants by CNF1. In contrast to CNF1, DNT did not modify Rho/Ras chimeras or the switch II peptide (Asp59 through Asp78). Glucosylation of RhoA at Thr37 blocked deamidation by DNT but not by CNF. The data indicate that CNF1 recognizes Rho GTPases exclusively in the switch II region, whereas the substrate recognition by DNT is characterized by additional structural requirements. E. coli cytotoxic necrotizing factor 1 the active fragment of CNF1 consisting of amino acid residues 709 through 1014 Bordetella dermonecrotic toxin the active fragment of DNT consisting of amino acid residues 1136 through 1451 glutathione S-transferase pheochromocytoma cells polymerase chain reaction polyacrylamide gel electrophoresis matrix-assisted laser desorption-ionization time of flight mass spectrometry guanosine 5′-3-O-(thio)triphosphate Rho GTPases (e.g. Rho, Rac, and Cdc42) participate in the regulation of the actin cytoskeleton (1Hall A. Science. 1998; 279: 509-514Crossref PubMed Scopus (5220) Google Scholar, 2Takai Y. Sasaki T. Tanaka K. Nakanishi H. Trends Biochem. Sci. 1995; 20: 227-231Abstract Full Text PDF PubMed Scopus (366) Google Scholar). Whereas Rho subtype proteins induce formation of stress fibers and adhesion complexes, Rac is involved in formation of lamellipodia and Cdc42 induces microspikes (3Kozma R. Ahmed S. Best A. Lim L. Mol. Cell. Biol. 1995; 15: 1942-1952Crossref PubMed Scopus (883) Google Scholar, 4Ridley A.J. Paterson H.F. Johnston C.L. Diekmann D. Hall A. Cell. 1992; 70: 401-410Abstract Full Text PDF PubMed Scopus (3076) Google Scholar, 5Nobes C.D. Hall A. Cell. 1995; 81: 53-62Abstract Full Text PDF PubMed Scopus (3735) Google Scholar). Beside their roles in the organization of the actin cytoskeleton, Rho proteins act as molecular switches in various signal transduction processes (6Van Aelst L. D'Souza-Schorey C. Genes Dev. 1997; 11: 2295-2322Crossref PubMed Scopus (2097) Google Scholar, 7Narumiya S. J. Biochem. ( Tokyo ). 1996; 120: 215-228Crossref PubMed Scopus (361) Google Scholar). Rho proteins are the preferred substrates for several bacterial protein toxins. Exoenzyme C3 from Clostridium botulinum and related C3-like transferases ADP-ribosylate RhoA, B, and C at Asn41thereby inhibiting the biological activity of the GTPases (8Aktories K. Braun U. Rösener S. Just I. Hall A. Biochem. Biophys. Res. Commun. 1989; 158: 209-213Crossref PubMed Scopus (215) Google Scholar, 9Braun U. Habermann B. Just I. Aktories K. Vandekerckhove J. FEBS Lett. 1989; 243: 70-76Crossref PubMed Scopus (97) Google Scholar, 10Chardin P. Boquet P. Madaule P. Popoff M.R. Rubin E.J. Gill D.M. EMBO J. 1989; 8: 1087-1092Crossref PubMed Scopus (422) Google Scholar, 11Sekine A. Fujiwara M. Narumiya S. J. Biol. Chem. 1989; 264: 8602-8605Abstract Full Text PDF PubMed Google Scholar). Rho proteins are monoglucosylated by members of the family of large clostridial cytotoxins (e.g. Clostridium difficile toxins A and B) (12Aktories K. Just I. Trends Cell Biol. 1995; 5: 441-443Abstract Full Text PDF PubMed Scopus (75) Google Scholar, 13Just I. Selzer J. Wilm M. Von Eichel-Streiber C. Mann M. Aktories K. Nature. 1995; 375: 500-503Crossref PubMed Scopus (883) Google Scholar, 14Just I. Wilm M. Selzer J. Rex G. von Eichel-Streiber C. Mann M. Aktories K. J. Biol. Chem. 1995; 270: 13932-13936Abstract Full Text Full Text PDF PubMed Scopus (419) Google Scholar). The toxins modify RhoA at Thr37 (Thr35 of Rac and Cdc42), a modification which blocks the interaction of the GTPases with their effectors (15Sehr P. Joseph G. Genth H. Just I. Pick E. Aktories K. Biochemistry. 1998; 37: 5296-5304Crossref PubMed Scopus (171) Google Scholar,16Herrmann C. Ahmadian M.R. Hofmann F. Just I. J. Biol. Chem. 1998; 273: 16134-16139Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar). Rho family GTPases are also the targets for cytotoxic necrotizing factors (CNF)1 1 and 2 fromEscherichia coli and the dermonecrotizing toxin (DNT) produced by various Bordetella species. CNF and DNT are ∼115 and ∼165 kDa proteins which share a region of homology at their C termini harboring the enzyme domain of the toxins (17Walker K.E. Weiss A.A. Infect. Immun. 1994; 62: 3817-3828Crossref PubMed Google Scholar). In culture cells, the toxins induce actin polymerization and inhibit cytokinesis resulting in formation of multinucleated cells (18Falzano L. Fiorentini C. Donelli G. Michel E. Kocks C. Cossart P. Cabanié L. Oswald E. Boquet P. Mol. Microbiol. 1993; 9: 1247-1254Crossref PubMed Scopus (162) Google Scholar, 19Fiorentini C. Donelli G. Matarrese P. Fabbri A. Paradisi S. Boquet P. Infect. Immun. 1995; 63: 3936-3944Crossref PubMed Google Scholar, 20Oswald E. Sugai M. Labigne A. Wu H.C. Fiorentini C. Boquet P. O'Brien A.D. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3814-3818Crossref PubMed Scopus (169) Google Scholar). Recently it has been reported that CNF and DNT act on Rho GTPases by deamidation of glutamine 63 of RhoA, thereby inhibiting the GTPase activity of Rho. Because Gln63 is essential for GTP hydrolysis, deamidation causes persistent activation of the GTPase resulting in strong formation of stress fibers of CNF- or DNT-treated cells. In addition to their deamidase activity, both toxins possessin vitro transglutaminase activity to attach primary amines onto Rho GTPases. Substrates of CNF and DNT are Rho subfamily members including Rac and Cdc42. In the present communication the substrate recognition of Rho GTPases by CNF1 and DNT was studied. Using GTPase chimeras of RhoA and Ha-Ras which is not a substrate of the toxins, we identified the switch II region of Rho as being sufficient for recognition by CNF1. Accordingly, a peptide consisting of amino acid residues Asp59 through Asp78 of RhoA was deamidated and/or transglutaminated by CNF1. By contrast, the structural requirements for substrate recognition by DNT are more stringent. For protein purification, E. coli strains carrying pGEX plasmids with the coding sequence for the respective GTPases, GTPase chimera, CNF1 (either as full-length or as the catalytic C-terminal part (ΔCNF1, amino acid residues 709–1014), or DNT (the catalytic C-terminal part (ΔDNT, amino acid residues 1136–1451) were grown in LB medium and induced with 0.2 mmisopropyl-1-thio-β-d-galactopyranoside at OD 0.5. The cells were harvested after 3–6 h and the glutathioneS-transferase (GST) fusion proteins were purified by means of glutathione-Sepharose (Amersham Pharmacia Biotech). Unstable proteins were kept as GST fusion proteins (Rho115Ras, Ras59Rho115Ras, ΔDNT, and full-length CNF1); otherwise, the proteins were subjected to thrombin cleavage to remove GST. The GTPase chimeras were constructed using the splicing by overlap extension method described previously (21Horton R.M. Hunt H.D. Ho S.N. Pullen J.K. Pease L.R. Gene ( Amst. ). 1989; 77: 61-68Crossref PubMed Scopus (2641) Google Scholar). In brief, two polymerase chain reactions (PCR) were performed, each amplifying the sequences to be fused. The products of the two first PCRs were pooled and cycled in a third PCR, in which the overhanging sequences act as primers. We used pGEX2T-RhoA (wild-type, WT) and pGEX2TGL-Ha-Ras (wild-type) as templates with the different primers listed in Table I and pGEX primers either annealing 5′ or 3′ of the multiple cloning site of pGEX (Table I). The product of the second PCR was subjected toBamHI and EcoRI cleavage and subcloned into a pGEX2TGL vector. The sites of splicing are numbered by Rho nomenclature. The “sandwich” chimeras Ras55Rho70Ras and Ras59Rho70Ras were constructed with splicing by overlay extension by using the primers for Ras55Rho and Ras59Rho, respectively, with Rho70Ras serving as template. Ras59Rho115Ras was constructed by using the primers for Ras59Rho with Rho115Ras as a template. All constructs were checked for proper sequences.Table IPrimers used for construction of chimerasRas55Rho:Ras5′-CACAAAGCCAACAGGCACGTCTC-3′Ras55Rho:Rho5′-GCCTGTTGGCTTTGTGGGACAC-3′Ras59Rho:Ras5′-CCAGCTGTGTCCAGGATGTCCAAC-3′Ras59Rho:Rho5′-GACATCCTGGACACAGCTGGGC-3′Rho70Ras:Rho5′-GTACTGGTCCCGCAGGCGATC-3′Rho70Ras:Ras5′-GATCGCCTGCGGGACCAGTAC-3′Rho78Ras:Rho5′-GAGGAAGCCATCGGTATCTGGG-3′Rho78Ras:Ras5′-GATACCGATGGCTTCCTCTGTG-3′Rho115Ras:Rho5′-CTTGTTCCCCACCAGGATGATG-3′Rho115Ras:Ras5′-CATCATCCTGGTGGGGAACAAG-3′pGEX 5′ of MCSaMCS, multiple cloning sequence.5′-TAGCATGGCCTTTGCAGGG-3′pGEX 3′ of MCS5′-TGTGTCAGAGGTTTTCACCG-3′a MCS, multiple cloning sequence. Open table in a new tab Mutants were constructed from pGEX2T-RhoA (wild-type) or pGEX2T-Ha-Ras (wild-type) by PCR in the presence of two primers (sense and corresponding antisense) carrying a base mismatch encoding the proper mutant. The parental DNA was eliminated using the restriction enzyme DpnI, which digests methylated DNA. The PCR products were transformed into Epicurean Blue XL-1 ultracompetent cells (Stratagene). After verifying the mutation by sequencing, the plasmids were transformed into E. coli BL21 for protein expression. The sense primers for the various mutants are listed in Table II.Table IISense primers used for site-directed mutagenesisR68A RhoA5′-GGAAGATTATGATGCCCTGAGGCCCCTCTCC-3′L72Q RhoA5′-GCCTGAGGCCCCAGTCCTACCCAGATACC-3′K98Q RhoA5′-GAAAACATCCCAGAACAGTGGACCCCAG-3′H105R RhoA5′-CCAGAAGTCAAGCGTTTCTGTCCCAACG-3′A66R Ha-Ras5′-GAAGAGTATAGTCGCATGCGGGACCAG-3′Q70L Ha-Ras5′-CATGCGGGACCTGTACATGCGCACAG-3′ Open table in a new tab Rat pheochromocytoma cells (PC12) were cultivated on plastic dishes in Dulbecco's modified Eagle's medium supplemented with 10% horse serum, 5% fetal calf serum, penicillin (4 mm), and streptomycin (4 and kept at in a with 10% The cells were microinjected with or by means of a and for h with full-length GTPase or chimeric protein was with or CNF1 or DNT in a 1 1 and for at The proteins were by and the transglutaminated proteins were the gel was to the of proteins in each RhoA, RhoA or Rho/Ras chimeras were at in a After addition of 2 which was as described T. Biophys. PubMed Scopus Google the in at to the of at was in a the of from the GTPases with CNF1, we a In the presence of and with to thereby the The of in the reaction is to the of RhoA, or Rho/Ras chimeras were in a 1 1 and the of the enzyme reaction for and of The were at to addition of CNF1 as in the The in was at at in a RhoA was in a 2 and 1 in the presence or of C. difficile toxin or in and 2 in the presence or of C. botulinum C3 toxin at for RhoA switch II peptide was for h at with or CNF1 in the presence of in a 1 2 and 1 a of the RhoA switch II peptide of the reaction was with A of acid in was and and were for and peptide were in Using the method of 1 of the was on the and to several at was on a mass with a laser were in the in with has been that Rho, Rac, and Cdc42 are deamidated by CNF1 M. Selzer J. A. Aktories K. G. Infect. Immun. 1998; Google Scholar). Ha-Ras is a substrate for CNF1, the of with deamidation was in a enzyme that addition of the active fragment of CNF1 of in the presence of RhoA but not in the presence of Ras indicating that the GTPase is not modified by CNF1. Because Rho and Ha-Ras in the amino acid residues the site of modification in Rho we a Ha-Ras with acid of acid at 63 of the Ras was not deamidated by of amino of RhoA, and Ha-Ras that the switch II region of the Rho is the for deamidation or transglutamination by CNF and RhoA proteins were constructed with amino Arg68 or Leu72 to the respective residues of The peptide Asp59 through Asp78 was as a substrate for By the that Ha-Ras is not a substrate for chimeras of Rho and Ha-Ras were constructed to the minimal amino acid sequence of Rho allowing the modification by we constructed Rho115Ras and Ras55Rho chimeras that the Rho is which both the switch II region of The chimeras were in a transglutaminase with as a primary a which is by at the proteins by and for Rho, the Ras55Rho chimera was transglutaminated by the Rho115Ras chimera was substrate for chimera was we Rho115Ras as a GST fusion protein and it with GST fusion proteins of RhoA and Hall and reported that amino acid residues through of Ras are sufficient to in cells A.J. Paterson H.F. Hall A. 1993; 8: Google Scholar). active Ras is to induce formation in PC12 cells I. H. A. J. Cell. PubMed Scopus Google Scholar). we CNF1 was to induce formation in PC12 cells microinjected with Ras55Rho to toxin PC12 cells were grown on plastic microinjected with and with GST fusion protein of the CNF1 holotoxin for Whereas cells CNF1 processes cells developed after CNF1 treatment B) indicating activation of the Ras chimera by CNF1. Because with the Ras55Rho and Rho115Ras chimeras that the the C of Rho are essential for substrate recognition by we chimeras are modified by the The chimera, Ras59Rho115Ras, was substrate for deamidation by of the of the RhoA in Ha-Ras in the chimera We chimera in the transglutamination at of The chimera was a substrate for whereas Rho was transglutaminated at of CNF1 were for transglutamination of Ras59Rho78Ras Rho sequences of or amino acid residues and did not as substrates of CNF1 not that were to protein we the of the chimeras to chimeras and were to indicating a proper of the proteins The with the different chimeras are in of Rho/Ras chimeras to as substrates for CNF1 were at by the and/or the transglutamination substrate as of transglutamination with substrate for from of Rho Y. Y. U. Biol. 1997; PubMed Scopus Google and by means of the we identified amino and residues through of Rho which are and are in Rho, Rac, and Cdc42. amino were to the corresponding Ras All proteins were of in the indicating a protein We the deamidation of the RhoA proteins by in the in A and B, whereas the and the mutants were deamidated by and mutants did not as substrates or were modified by the The of the modification of the different and was not the and are sufficient for CNF1 substrate a Ha-Ras carrying at and a at was constructed and for activity in the transglutaminase and was not modified by A peptide of the which the switch II region of RhoA was for to as substrate for CNF1 in the The switch II peptide was with RhoA at two different and in the presence of 1 in after addition of was from the at a with The in the modification was as a for the peptide in with the protein A peptide with the did not after addition of the switch II peptide was modified by the peptide was with CNF1 in the presence of the was by mass in after treatment a new peptide characterized by in mass by was indicating the of onto the switch II of the transglutaminated RhoA peptide The RhoA peptide was in the presence of or with for the were by is the Rho peptide and a new peptide with a mass of by of onto the Rho the in mass of 1 by deamidation was not the reaction was not we with the related Bordetella deamidase DNT in to substrate and substrate The active C-terminal part of Bordetella DNT was as a GST fusion protein to be more For of the two was also used as a GST fusion for deamidated RhoA, Rac and Cdc42 DNT the amino acid residues of Rho for substrate recognition as CNF1, the transglutaminase of both toxins were in the presence of with the RhoA mutants and did not modify the mutants RhoA and RhoA with in the switch II RhoA and RhoA were transglutaminated by both toxins. We the Ras55Rho and Rho115Ras chimeras with and in the transglutamination In contrast to both chimeras were not modified by has been reported that CNF1, DNT RhoA in the Y. T. J. M. J. Cell Sci. 1995; Google Scholar). the that GTP of modification by chimera was with to toxin the Rho chimeras were not modified by DNT after with The that the substrate recognition by DNT is more for CNF1. Because causes in the switch I region of Rho, we the effects of of RhoA at Thr37 by C. difficile toxin on modification by in of Rho by toxin inhibited the transglutamination by DNT but not by CNF1. By contrast, of Rho at by a modification that of the switch I region did not transglutamination by CNF1 or In contrast to various bacterial protein toxins GTPases including large clostridial cytotoxins and C3 G. Aktories K. 1998; PubMed Scopus Google the E. coli cytotoxic necrotizing factors CNF1 and activate Rho GTPases. The toxins Rho GTPases at Gln63 of Rho (Gln61 of Rac and Cdc42) to inhibit the and GTP thereby the switch reaction of the GTPase G. P. Wilm M. Selzer J. Mann M. Aktories K. Nature. 1997; PubMed Scopus Google Scholar, G. E. M. P. S. Fiorentini C. Boquet P. Nature. 1997; PubMed Scopus Google Scholar). we reported that CNF1 in activity in addition to deamidase activity G. Selzer J. M. Aktories K. J. Biol. Chem. 1998; 273: Full Text Full Text PDF PubMed Scopus Google Scholar, Dev. 1998; 8: PubMed Scopus Google Scholar). Here we to the recognition site of Rho GTPases for CNF1. and A.J. E. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google reported that CNF1 not activate the protein or in cells, that Ras is not by the In with we that Ras is not modified by CNF1. more the structural requirements for substrate recognition by CNF1, we constructed several chimeras consisting of Rho and The active toxin fragment acid residues of deamidated and transglutaminated chimeras consisting of Ras harboring the switch II region through of Rho. indicate that the switch II region of Rho is sufficient for substrate recognition by CNF1 and the switch I region the region through are for interaction with CNF1. was by the that the peptide Asp59 through the switch II region of RhoA was to as a substrate for the active fragment of CNF1. as for the chimera the peptide was a substrate for CNF1 RhoA, that additional not essential for modification by the the substrate of of Rho, which is glutamine in Rac and Cdc42), Rho proteins including Rac and Cdc42 possess amino acid sequences in the switch II the substrate requirements in are in with that Rac and Cdc42 are modified by CNF1 M. Selzer J. A. Aktories K. G. Infect. Immun. 1998; Google and it that Rho GTPases, including not are also substrates of the amino which are involved in interaction with CNF1, we amino and for site-directed by using the data of RhoA Y. Y. U. Biol. 1997; PubMed Scopus Google Scholar). of Arg68 or Leu72 of RhoA with the corresponding amino acid in Ha-Ras and modification of the By contrast, of and which are the switch II region, with the corresponding residues of Ha-Ras did not the modification of RhoA, and the of from RhoA was that from Rho. both Arg68 and Leu72 of RhoA are essential for recognition by CNF1, are not sufficient for is from the that of the corresponding amino in Ras by and did not it a substrate for CNF1. The that the switch I region of Rho is not for substrate recognition by CNF1 in vitro was in intact cells. of the Ras55Rho chimera into PC12 cells and treatment with the CNF1 which in contrast to 709 through is to cells, a Ras-like of CNF1 to cells did not to are by interaction of the Ras55Rho chimera with Ras effectors by the intact switch I region of Ras and the deamidation of the chimera at Gln63 thereby the of the chimeric are in with the by Hall and A.J. Paterson H.F. Hall A. 1993; 8: Google that a active chimera, the switch I region of Ras the Ras effects as A.J. Paterson H.F. Hall A. 1993; 8: Google Scholar). the is a Ras in contrast to of active Ras the of active RhoA not induce in PC12 cells The Bordetella dermonecrotizing toxin DNT is toxin which Rho GTPases. toxin at C 1136–1451) with the active region of CNF1 (17Walker K.E. Weiss A.A. Infect. Immun. 1994; 62: 3817-3828Crossref PubMed Google Scholar, E. G. M. Boquet P. M. Mol. Microbiol. 1997; PubMed Scopus Google Scholar). CNF1, DNT deamidation of Gln63 of Rho Y. M. T. J. M. Proc. Natl. Acad. Sci. U. S. A. 1997; PubMed Scopus Google Scholar). DNT transglutaminase activity G. Aktories K. PubMed Scopus Google Scholar). We the structural requirements for substrate recognition by and with of Arg68 and Leu72 to the amino of Ras inhibited modification by in contrast to and did not of the Rho/Ras chimeras as substrates for deamidation or Accordingly, the peptide the switch II region of RhoA (Asp59 through was not modified by Because the Ras55Rho the Rho115Ras chimera were modified by ΔDNT, it be that structural both and C-terminal to the switch II region are essential for substrate recognition by it is that the structural requirements for substrate recognition by DNT are more for CNF1. In with are that modification of Rho by but not by CNF1, on the to Rho Y. T. J. M. J. Cell Sci. 1995; Google Scholar). Using the active fragment ΔDNT, we that but not the of Rho is a substrate for deamidation and that in addition to the switch II region, the switch I region, which is involved in substrate recognition by A of the switch I region in substrate recognition by DNT is also by the that of Rho by C. difficile toxin deamidation or Rho at Thr37 which is in the switch I region I. Selzer J. Wilm M. Von Eichel-Streiber C. Mann M. Aktories K. Nature. 1995; 375: 500-503Crossref PubMed Scopus (883) Google Scholar). of Rho by C3 at which is the switch I region, did not DNT effects on Rho. By contrast, as substrate recognition by CNF1 exclusively on the sequence of the switch II region, it that of Rho and or by toxins not modification of the GTPase by CNF1. In the switch II region of Rho was identified as the substrate recognition site for CNF1. structural requirements for substrate recognition by CNF1 are by a peptide covering amino acid residues Asp59 through Asp78 of Rho. By contrast, the substrate recognition by DNT is more in addition to the switch II region, sites including the switch I region of Rho. We for the Ha-Ras and for
28
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Anne J. Ridley, Hugh F. Paterson, Caroline L. Johnston et al. · Cell · 1992 · 3.7K citations
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension
Robert M. Horton, Henry D. Hunt, Steffan N. Ho et al. · Gene · 1989 · 3.1K citations
Glucosylation of Rho proteins by Clostridium difficile toxin B
Ingo Just, Jörg Selzer, Matthias Wilm et al. · Nature · 1995 · 1K citations